Articles Tagged With:
-
Study: Women Use Female Condoms More When Their Partners Approve
Female (internal) condoms were hailed as a method that gave women control over their disease protection. But one factor was overlooked: Women’s reproductive health decisions are influenced by male partners.
-
Marketing a Male Contraceptive Plays Role in Availability
The marathon race for finding an effective and safe male contraceptive has reached a hurdle that was not as much of a barrier for the research race to bring the first female contraceptive to market: Someone needs to prove men want their own contraceptive and will use whatever method succeeds.
-
Fledgling Research Holds Promise for Safe, On-Demand Male Contraceptive Pill
Researchers have found a possible way to target soluble adenylyl cyclase (sAC:ADY10), which is essential for male fertility.
-
New Male Contraceptive Options in the Pipeline
There is a wide variety of potential male contraceptive products in the research pipeline. Hormonal contraceptive products have been studied a long time, but nonhormonal products also are under study.
-
New Male Contraceptives May Be on the Horizon
Researchers across the world are studying hormonal and nonhormonal male contraceptive products in hopes of being the first to bring a new, reversible contraceptive for men to market within the next 10 to 20 years.
-
What Kind of AV Block?
The ECG in the figure was obtained from a young adult who presented to the emergency department with dizziness, a near syncopal episode, and chest discomfort. Does this ECG suggest AV block is the cause of his symptoms?
-
Oliceridine Injection (Olinvyk)
Oliceridine should be prescribed to adults to manage acute pain severe enough to require intravenous opioid analgesic and for whom alternative treatment has not worked.
-
Preventing Recurrent Stroke or Death After Ischemic Stroke, TIAs
The combination of ticagrelor and aspirin compared to aspirin alone was superior in reducing the risk of stroke or death within 30 days of an acute ischemic stroke or transient ischemic attack.
-
Cilostazol Appears Effective for Long-Term Secondary Stroke Prevention
More trials in Western countries should be initiated to assess the effects of cilostazol treatment on cognitive decline and functional outcomes, as well as on the progression of small vessel disease in the brain. Studies from Asia suggest it is a promising treatment, but it has not been studied sufficiently in clinical trials.
-
2020 Updated LTBI Treatment Guidelines
A committee recommended three rifamycin-based regimens and two alternate six- or nine-month isoniazid monotherapy regimens for latent tuberculosis infection treatment. They gave priority to shorter-course regimens with similar efficacy, higher rates of completion, and favorable tolerability compared with the former standard nine-month regimen of isoniazid.